+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Single Photon Emission Computed Tomography Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 186 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011744
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global Single Photon Emission Computed Tomography (SPECT) market is transforming healthcare imaging, enabling providers to deliver more actionable diagnostics and streamline therapeutic planning. Leading technologies, innovative software, and evolving clinical applications are positioning SPECT systems as crucial tools in the advancement of precision medicine and patient-centered care.

Market Snapshot: SPECT Market Growth, Trends, and Outlook

The Single Photon Emission Computed Tomography market grew from USD 2.19 billion in 2024 to USD 2.28 billion in 2025. It is projected to expand at a CAGR of 4.08%, reaching USD 3.02 billion by 2032.

This steady momentum underscores growing adoption across clinical specialties, driven by accuracy demands and operational efficiencies. Robust investment in next-generation detector technologies, software enhancements, and hybrid platforms continues to accelerate innovation cycles. Healthcare institutions of all scales are integrating advanced SPECT systems to strengthen diagnostic portfolios and support evolving patient care models.

Scope & Segmentation: Comprehensive Market Coverage

This research encompasses end-to-end analysis of the SPECT market, with multi-level segmentation for actionable insights. The report examines developments and trends in the following areas:

  • Detector Types: CZT, NaI scintillation, solid state, germanium semiconductor, silicon photomultiplier.
  • End Users: Diagnostic centers, hospitals (private, public), research institutes.
  • Product Configurations: Dual head, single head, triple head systems.
  • Clinical Applications: Cardiology, neurology, oncology.
  • Regional Dynamics: Americas (North America: United States, Canada, Mexico; Latin America: Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East & Africa (Europe: UK, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland; Middle East: UAE, Saudi Arabia, Qatar, Turkey, Israel; Africa: South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan).
  • Company Developments: GE HealthCare Technologies, Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems, Spectrum Dynamics, Digirad, Neusoft, Mediso, Shimadzu, Hitachi.

Key Takeaways: Strategic Insights for SPECT Market Stakeholders

  • Adoption of solid state detector technologies is improving image resolution and throughput, supporting precision in high-demand clinical environments.
  • Integration of advanced analytics and artificial intelligence is streamlining SPECT image interpretation, enabling more reliable and efficient clinical workflows.
  • Demand for flexible and space-saving systems is rising among outpatient and diagnostic centers, while major hospitals favor integrated hybrid platforms for multi-modality imaging.
  • Regional growth is influenced by variations in public funding, healthcare infrastructure maturity, and strategic initiatives to expand nuclear imaging access.
  • Leading companies are leveraging partnerships, cloud analytics, and modular designs to address specialized end-user requirements and regulatory complexities.

Assessing the Tariff Impact: Navigating New US Policy Challenges

The imposition of United States tariffs in 2025 is introducing supply chain pressures, especially regarding critical imported detector components and electronic subsystems. Device manufacturers are reevaluating sourcing and shifting towards domestic production to offset cost volatility. These changes are influencing supplier relationships, R&D investments, and the need for more adaptable, modular engineering strategies, reinforcing industry resilience against policy-driven disruptions.

Methodology & Data Sources: Ensuring Reliability and Rigor

This report employs a blended research methodology. Primary data was gathered via in-depth interviews with senior executives at imaging system manufacturers, radiopharmaceutical providers, and healthcare decision-makers. Secondary research validated these insights using industry journals, regulatory filings, and market white papers. Triangulation, patent tracking, and expert peer review strengthened the accuracy of findings.

Why This Report Matters for Senior Decision-Makers

  • Equips leaders with actionable insights into technology adoption, regulatory adaptation, and procurement planning for advanced SPECT imaging solutions.
  • Supports strategic investment and partnership decisions by benchmarking market trends and competitor movements across regions and segments.
  • Helps anticipate and navigate operational disruption from tariff policy shifts and supply chain realignments.

Conclusion

Single Photon Emission Computed Tomography remains central to evolving diagnostic and therapeutic paradigms. Informed decision-making, proactive innovation, and supply chain agility will enable stakeholders to sustain leadership and capture growth opportunities in this dynamic marketplace.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Integration of artificial intelligence algorithms to enhance image reconstruction accuracy and diagnostic confidence in SPECT scans
5.2. Development of portable SPECT imaging devices enabling point-of-care cardiac and neurological assessments in remote settings
5.3. Adoption of novel radiopharmaceutical tracers targeting neuroinflammation biomarkers to improve early detection of Alzheimer’s disease
5.4. Expansion of hybrid SPECT/CT imaging systems for superior anatomical localization in oncology diagnostics
5.5. Growing demand for personalized dosimetry protocols in radiopharmaceutical therapy planning based on quantitative SPECT metrics
5.6. Regulatory approvals of new 99mTc-labeled myocardial perfusion agents for improved chronic coronary disease management
5.7. Implementation of cloud-based SPECT data management platforms for enhanced multicenter collaboration and telemedicine analyses
5.8. Advancements in solid-state detector technologies to boost sensitivity and spatial resolution of next-generation SPECT cameras
5.9. Increasing adoption of standardized quantification software for reproducible longitudinal monitoring of Parkinson’s disease progression via SPECT
5.10. Surge in clinical studies evaluating PSMA-targeted radiotracers for prostate cancer staging using SPECT molecular imaging modalities
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Single Photon Emission Computed Tomography Market, by Detector
8.1. Czt
8.2. Nai Scintillation
8.3. Solid State
8.3.1. Germanium Semiconductor
8.3.2. Silicon Photomultiplier
9. Single Photon Emission Computed Tomography Market, by End User
9.1. Diagnostic Centers
9.2. Hospitals
9.2.1. Private Hospitals
9.2.2. Public Hospitals
9.3. Research Institutes
10. Single Photon Emission Computed Tomography Market, by Product
10.1. Dual Head
10.2. Single Head
10.3. Triple Head
11. Single Photon Emission Computed Tomography Market, by Application
11.1. Cardiology
11.2. Neurology
11.3. Oncology
12. Single Photon Emission Computed Tomography Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Single Photon Emission Computed Tomography Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Single Photon Emission Computed Tomography Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. GE HealthCare Technologies Inc.
15.3.2. Siemens Healthineers AG
15.3.3. Koninklijke Philips N.V.
15.3.4. Canon Medical Systems Corporation
15.3.5. Spectrum Dynamics Medical Ltd.
15.3.6. Digirad Corporation
15.3.7. Neusoft Medical Systems Co., Ltd.
15.3.8. Mediso Medical Imaging Systems Ltd.
15.3.9. Shimadzu Corporation
15.3.10. Hitachi, Ltd.

Companies Mentioned

The companies profiled in this Single Photon Emission Computed Tomography market report include:
  • GE HealthCare Technologies Inc.
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Spectrum Dynamics Medical Ltd.
  • Digirad Corporation
  • Neusoft Medical Systems Co., Ltd.
  • Mediso Medical Imaging Systems Ltd.
  • Shimadzu Corporation
  • Hitachi, Ltd.

Table Information